Insider Moves: Merus Executive Sells Significant Stock Holdings

New insider activity at Merus ( (MRUS) ) has taken place on December 10, 2025.Claim 50% Off TipRanks Premium and Invest with Confidence Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential VP Controller, PAO Harry Shuman has recently sold 1,700 shares of Merus stock, amounting to a total transaction value of $163,370. Recent Updates on MRUS stock Merus N.V. recently held an extraordinary general meeting where shareholders approved a transaction agreement with Genmab A/S, involving Genmab’s subsidiary offering to purchase all outstanding shares of Merus at $97.00 per share. This acquisition is expected to significantly impact Merus’s operations and governance, aligning it with Genmab’s strategic interests. Analysts have rated Merus stock as a Hold with a $96.00 price target, reflecting concerns over the company’s weak financial performance, characterized by declining revenue and substantial losses. Despite strong upward momentum in technical analysis, overbought signals and a negative P/E ratio suggest caution, limiting the stock’s valuation appeal. Spark’s Take on MRUS Stock According to Spark, TipRanks’ AI Analyst, MRUS is a Neutral. Merus’s overall stock score is primarily impacted by its weak financial performance, characterized by declining revenue and substantial losses. While technical analysis indicates strong upward momentum, the overbought signals suggest caution. The negative P/E ratio further reflects the company’s financial struggles, limiting its valuation appeal. To see Spark’s full report on MRUS stock, click here. More about Merus YTD Price Performance: 127.80% Average Trading Volume: 2,437,217 Technical Sentiment Signal: Buy Current Market Cap: $7.3B